资讯
The India launch of Eli Lilly's Mounjaro in India has triggered a huge wave of enquiries from those looking for its ...
Kilow will also provide access to treatments like GLP-1 medications like Ozempic, Wegovy ...
Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and protection from dementia may soon be added to the list.
Insurance companies face a growing challenge as they adapt to the rise of GLP-1 receptor agonists, such as Ozempic and Wegovy ...
Millions of dollars in a new state budget proposal could allow for the return of GLP-1 coverage for some state employees.
The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...
Nestle SA is launching GLP-1-friendly beverages under its Boost brand that contain a proprietary whey protein microgel technology, according to the company. Nestle said the innovation allows for more ...
Medications like Ozempic, Wegovy, and Zepbound have helped many Americans lose weight, but there are still some ...
A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated steatohepatitis (MASH) and looks ahead to the future promise of glucagon-like ...
What are the most concerning consequences of the drug and other weight-loss medicines? - Gastrointestinal and cardiovascular complications are among the most serious side effects ...
Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.
For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果